| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07501052 Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular… |
overall status: "Not Yet Recruiting" → "Completed" |
| 2026-06-04 | NCT07449936 COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901… |
Trial sites expanded: 46 -> 65 locations |
| 2026-06-04 | NCT07449923 CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901… |
Trial sites expanded: 48 -> 62 locations |
| 2026-05-21 | NCT07482176 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With… |
Trial sites expanded: 36 -> 46 locations |
| 2026-05-20 | NCT07359456 Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic… |
date change Primary completion pushed: 2028-03 -> 2029-08 |
| 2026-05-20 | NCT07359456 Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic… |
date change Completion pushed: 2032-03 -> 2033-08 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07640997 Real-world Study of Aflibercept 8 mg in nAMD | Recruiting | |
| 2026-05-29 | NCT07614776 A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA®… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07118670 | High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes | Proliferative Diabetic Retinopathy (PDR) | Active, Not Recruiting |
| Phase 3 | |||
| NCT07389980 | Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose… | Polypoidal Choroidal Vasculopathy | Recruiting |
| NCT07317934 | Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related… | Neovascular Age-Related Macular Degeneration (nAMD) | Recruiting |
| NCT05407636 | Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD | AMD | Recruiting |
| NCT07489131 | Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With… | Diabetic Macular Edema | Recruiting |
| NCT03803553 | Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer | Metastatic Colon Cancer | Recruiting |
| NCT07482176 | Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With… | Neovascular Age-Related Macular Degeneration (nAMD) | Recruiting |
| NCT07449923 | CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901… | Diabetic Macular Edema | Recruiting |
| NCT07449936 | COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901… | Diabetic Macular Edema | Recruiting |
| NCT07489586 | A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related… | Neovascular Age-Related Macular Degeneration (nAMD) | Not Yet Recruiting |
| NCT06556368 | A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp… | Wet Age-related Macular Degeneration | Active, Not Recruiting |
| NCT06668064 | A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)… | Wet Age Related Macular Degeneration | Active, Not Recruiting |
| NCT06683742 | A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)… | Wet Age Related Macular Degeneration | Active, Not Recruiting |
| NCT06856577 | Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With… | Neovascular Age-Related Macular Degeneration (nAMD) | Active, Not Recruiting |
| NCT07614776 | A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA®… | Neovascular Age-related Macular Degeneration | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT07440225 | A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) | Macular Degeneration | Recruiting |
| NCT07496567 | A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) | Macular Degeneration | Recruiting |
| Phase 2 | |||
| NCT07359456 | Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic… | Metastatic Colorectal Cancer | Not Yet Recruiting |
| NCT04587128 | Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC | Metastatic Colorectal Cancer | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06047379 | Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma… | Diffuse Astrocytoma, IDH-Mutant | Recruiting |
| NCT06850922 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603… | Diabetic Macular Edema | Active, Not Recruiting |
| Phase 1 | |||
| NCT07567235 | Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin Fibrosis | Radiation-Induced Skin Fibrosis | Recruiting |
| NCT06817343 | A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU) | Neovascular Age-Related Macular Degeneration (nAMD) | Active, Not Recruiting |
| NCT02298959 | Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced… | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Active, Not Recruiting |
| Not specified | |||
| NCT06315556 | An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a… | Retinopathy of Prematurity | Recruiting |